Moreover, the percentage of CD68+CD40+, but not CD68+CD86+ cells as well as levels of IL-1β were further enhanced when exposed to A20 siRNA, whereas the absence of CYLD unaltered macrophage function in cHL patients. The gene discussed is CD68; the disease is classic Hodgkin lymphoma.